ICU Medical, Inc. (FRA:IC7)
132.00
+6.00 (4.76%)
At close: Feb 20, 2026
ICU Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 307.96 | 308.57 | 254.22 | 208.78 | 552.83 |
Short-Term Investments | - | - | 1.7 | 5.55 | 15.76 |
Trading Asset Securities | 3.75 | 11.04 | 23.07 | 28.43 | - |
Cash & Short-Term Investments | 311.71 | 319.6 | 278.98 | 242.77 | 568.59 |
Cash Growth | -2.47% | 14.56% | 14.92% | -57.30% | 37.96% |
Accounts Receivable | 180.52 | 182.83 | 161.57 | 221.72 | 105.89 |
Other Receivables | - | - | 2.75 | 3.55 | 4.16 |
Receivables | 180.52 | 182.83 | 164.31 | 225.27 | 110.05 |
Inventory | 615.86 | 584.68 | 709.36 | 696.01 | 290.24 |
Prepaid Expenses | 32.31 | 27.6 | 27.38 | 37.96 | 21.07 |
Other Current Assets | 50.16 | 327.28 | 35.41 | 29.37 | 35.62 |
Total Current Assets | 1,191 | 1,442 | 1,221 | 1,235 | 1,030 |
Property, Plant & Equipment | 511.89 | 499.3 | 685.53 | 713.58 | 510.89 |
Long-Term Investments | 132.25 | 8.76 | 8 | 57.2 | 7.86 |
Goodwill | 1,500 | 1,433 | 1,472 | 1,449 | 43.44 |
Other Intangible Assets | 633.56 | 740.79 | 870.59 | 982.77 | 188.31 |
Long-Term Deferred Tax Assets | 25.89 | 24.21 | 37.3 | 31.47 | 42.6 |
Long-Term Deferred Charges | - | - | 3.44 | 5.16 | 2.83 |
Other Long-Term Assets | 56.61 | 56.11 | 79.88 | 41.02 | 55.01 |
Total Assets | 4,051 | 4,204 | 4,378 | 4,516 | 1,881 |
Accounts Payable | 154.37 | 148.02 | 150.03 | 215.9 | 81.13 |
Accrued Expenses | 213.2 | 203.02 | 152.26 | 149.66 | 94.7 |
Current Portion of Long-Term Debt | 18.75 | 51 | 51 | 29.69 | - |
Current Portion of Leases | 15.92 | 16.76 | 21.02 | 18.99 | 9.65 |
Current Income Taxes Payable | 10.4 | 17.33 | 7.71 | 6.2 | 1.45 |
Current Unearned Revenue | 33.84 | 30.36 | 31.64 | 30.84 | 12.65 |
Other Current Liabilities | 52.37 | 89.69 | 68.18 | 43.28 | 1.2 |
Total Current Liabilities | 498.86 | 556.18 | 481.84 | 494.56 | 200.78 |
Long-Term Debt | 1,266 | 1,532 | 1,578 | 1,624 | 1.48 |
Long-Term Leases | 47.68 | 43.11 | 54.93 | 62.77 | 36.04 |
Long-Term Unearned Revenue | - | - | 10.59 | 16.24 | - |
Long-Term Deferred Tax Liabilities | 37.76 | 48.81 | 55.87 | 126.01 | 1.49 |
Other Long-Term Liabilities | 76.47 | 58.73 | 74.04 | 102.46 | 24.92 |
Total Liabilities | 1,927 | 2,239 | 2,255 | 2,426 | 264.71 |
Common Stock | 2.47 | 2.45 | 2.41 | 2.4 | 2.13 |
Additional Paid-In Capital | 1,465 | 1,412 | 1,366 | 1,331 | 721.41 |
Retained Earnings | 690.89 | 690.16 | 807.85 | 837.5 | 911.79 |
Treasury Stock | -0.02 | -0.09 | -0.26 | -0.24 | -0.03 |
Comprehensive Income & Other | -34.63 | -139.4 | -53.08 | -80.98 | -19.27 |
Shareholders' Equity | 2,124 | 1,965 | 2,123 | 2,090 | 1,616 |
Total Liabilities & Equity | 4,051 | 4,204 | 4,378 | 4,516 | 1,881 |
Total Debt | 1,348 | 1,643 | 1,705 | 1,735 | 47.17 |
Net Cash (Debt) | -1,037 | -1,323 | -1,426 | -1,492 | 521.42 |
Net Cash Growth | - | - | - | - | 45.07% |
Net Cash Per Share | -41.62 | -54.25 | -59.18 | -62.53 | 23.94 |
Filing Date Shares Outstanding | 24.69 | 24.52 | 24.14 | 24 | 23.79 |
Total Common Shares Outstanding | 24.69 | 24.52 | 24.14 | 23.99 | 21.28 |
Working Capital | 691.69 | 885.8 | 739.43 | 740.64 | 829.03 |
Book Value Per Share | 86.03 | 80.16 | 87.96 | 87.11 | 75.94 |
Tangible Book Value | -9.49 | -208.33 | -219.62 | -342.1 | 1,384 |
Tangible Book Value Per Share | -0.38 | -8.50 | -9.10 | -14.26 | 65.05 |
Land | 176.97 | 177.09 | 278.25 | 274.06 | 243.38 |
Machinery | 681.57 | 647.26 | 725.66 | 637.1 | 492.19 |
Construction In Progress | 90.75 | 87.01 | 117.22 | 152.91 | 72.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.